(HealthDay News) — Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have comorbid type 2 diabetes, high body mass index, and a ...
The presence or absence of left ventricular hypertrophy may predict the effect of finerenone on heart failure hospitalization risk in patients with CKD and type 2 diabetes.
Performance measures extracted from GPS and user data differentiated between those with subjective cognitive decline, cognitively healthy adults ...